Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Product Type, Application & End-User The global robotic endoscopy devices market will witness a robust CAGR of 14.65%, valued at $1.60 billion in 2021, expected to appreciate and reach $5.49 billion by 2030, confirms Strategic Market Research. Endoscopes are mainly used for minimally invasive procedures or systems (STRAS). Robots in endoscopy are developed to overcome the limitations present in standard endoscopy procedures. Robotic endoscopy devices are of three types- robotic flexible endoscopy (MASTER and ENDOSAMURAI), robot-assisted rigid endoscopy, and active endoscopy, which comprises active flexible colonoscopy, active capsule endoscope, or Endoscopic capsule. The robotic endoscopy devices enable an ergonomic mapping of the surgeon's movements to remotely control the slave arms, thereby, facilitating the tissue manipulation. These are used to examine the presence of interior hollow organs in the body. The devices are placed in the body through natural openings or cavities such as the anus and the upper GI tract or incisions, especially in the case of arthroscopy. They are equipped with parts such as a camera or light at the tip of endoscopes, which further help the endoscopists analyze the internal organs of interest. Robotics allow a range of unconventional tactics for endoscopes to reduce trauma to the GI tract. GI endoscopy is used widely for the treatment of various diseases in the upper GI tract. More than 57.43 Mn gastrointestinal procedures are conducted in the United States on a yearly basis. Moreover, the GI endoscopy, is the largest market segment accouting for around 56% of the total procedure volume. Computer and robot-assisted surgeries focus on enhancing surgeons' interventional capabilities and overcoming the restrictions of minimally invasive surgical procedures. Many robotic endoscopy devices are under development or have been developed. These devices are mainly designed for therapeutic applications. The Annual Minimally Invasive Surgery Symposium (MISS) reported that the number of robotic general surgery procedures in the U.S. are more than 650,000 each year. Market Drivers - Rising Incidences of Chronic Diseases, High Adoption of Robotic Endoscopy Devices, and Rising Number of Market Players. Among all age groups, there is a rising prevalence of NCD/chronic diseases, like gastroesophageal reflux, pancreatic cancers, etc. because of an unhealthy lifestyle. The 2021 report from IFFGD, asserted that around 10%-15% of the total population is influenced by irritable bowel syndrome globally, including 25-45 million people afflected with the disease in the US, thereby demanding the higher need of high end technologies in the endoscopy for efficient treatment, which can boost up the market growth during the forecasted period. Due to the increase in the oveall usage of Master and Slave Transluminal Endoscopic Robot, Scorpion shaped endoscopic robot and Endoscopic Operation Robot, the market for global robotic endoscopy devices is approximated to rise exponentially. The high adaption rate of robotic endoscopy devices for the intervention of surgical processes & a rising number of market players developing new robotic endoscopy devices for various surgical procedures are driving the market growth. For instance, in the month of November in 2020, the experts especially from Vanderbilt University had created a robotic flexible endoscope with features like smart, self-governed, Magnetism, etc to prepare colonoscopies which are widely available, less expensive, safer and less painful. The rise in the geriatric population with chronic diseases is also a significant driver of the market growth. As per the report of WHO, 1 in 6 people in the world will be aged above 60 years by 2030, and by 2050, it will rise to 2.1 billion, and the people above 80 years is approximated to triple by 2050. Restraints - High Cost of Robotic Endoscopy Devices The increase in the cost of robotic endoscopy devices and the lack of trained professionals hinder the growth of the market for robotic endoscopy devices. Opportunities - Increase in Investments for Robotic System Development, Technological Advancements, and Initiation of Government Policies. The increase in investments in robotic system development, technological advancements, and government policies will further accelerate the expansion of the market for robotic endoscopy devices, offering significant opportunities for endoscopy market growth in the upcoming years which in turn will facilitate the overall prosperity of the market. Developing countries such as India, Africa, and China provide a vast amount of growth opportunities as they have a higher number of patients. As per World Economic Forum, the enlargement of the economies accounted for approximately 1/3rd of the global healthcare expenses in 2020. Also, the rapid growth of medical tourism and flexible regulations in the countries encourage the market players in those countries to expand their presence in emerging countries. Market Analysis Of Different Segments Covered in the Report Based on Product Therapeutic Biopsy (FNA and FNB) Polypectomy (Endoscopic submucosal dissection and Endoscopic Mucosal Resection) Biliary Stone Management & Drainage Hemostasis & Endoscopic suturing Esophageal & Colon Stricture Management Gastroesophageal Reflux Disease (GERD) & Obesity Diagnostics Based on Applications Laparoscopy Bronchoscopy Gastrointestinal devices market Colonoscopy Devices Market Based on End-User Ambulatory Surgical Center Hospital Others Regional Coverage Analysis North America U.S. Canada Rest of North America Europe France Spain Italy Rest of Europe U.K. Germany Asia Pacific China India South Korea Japan Rest of APAC LAMEA Brazil Argentina Saudi Arabia Uruguay Rest of LAMEA Segments Analysis & Insights Based on Product, the therapeutic segment dominated the market with the biggest market share of 98% in 2020, owing to the sheer focus on the increasing number of market players that are developing new robotic endoscopy devices for various surgical procedures. The surge in the adoption rate of robotic endoscopy devices for surgical intervention is also contributing to the segment's growth. Based on Applications, the laparoscopic segment dominated the market in 2020 with a market valuation of almost USD 1 billion in 2020 due to demand for laparoscopic diagnostic and therapeutic procedures. According to clevelandclinic.org,, more than 13 Mn laparoscopic procedures are conducted every year globally. The rising geriatric population is also propelling the overall growth of this segment. Based on End Users, the Hospitals portion contained the highest market share with around USD 15 billion in 2020. Factors such as the availability of funds for the hospitals in the developed regions, an increase in the population suffering from diseases, favorable reimbursement policies, and the increasing adoption of robotic endoscopic surgery devices for various surgical procedures are significantly driving the overall growth of this segment. Based on Regions, North America held the prominent market with 65% of the market share in 2020. The highest percentage of this North American region can primarily be because of the presence of the financial capability of the hospitals to develop and invest in robotic endoscopy devices. The increase in the geriatric population because the Census data of 2021 reveals that presently, around 16.5% of Americans, i.e., 54 million individuals, are older than 65 years and in 2030, the number is destined to reach seventy-four million. The well-established healthcare sector's general awareness of robot-assisted medical procedures, and the presence of a large number of market participants in the region also contribute to the segment's growth. Also, Colon cancer is projected to be the third-leading cause of cancer deaths in the US. As per the American Cancer Society, 1.9 million new cancer cases are diagnosed and 608,570 cancer deaths had occured in the US. Robotic Endoscopy Devices Market Report Coverage Report Attribute Details Forecast Period 2021-2030 Market size value in 2021 USD 1.60 Billion Revenue forecast in 2030 USD 5.49 Billion Growth rate 14.65% Base year for estimation 2021 Historical data 2017 - 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation By End-User, By Product, By Application, By Region. By Product Diagnostic and Therapeutic By Application Laparoscopy, Bronchoscopy, Gastrointestinal devices market and Colonoscopy devises market By End-User Hospitals and Ambulatory Surgical Centers By Region Asia Pacific, Europe, LAMEA and North America, Country Scope U.S. , Canada , France, Germany ,U.K. , China , Japan, India , South Korea, Mexico, Brazil ,U.A.E. etc. Company Usability Profiles Medrobotics Corporation, EndoMaster Pte Ltd, Auris Health, Inc., Johnson & Johnson Services, KARL STORZ, Stryker, TransEnterix Surgical, Inc., Medtronic, Brainlab AG, Smith + Nephew.,Intuitive Surgical, Engineering GmbH, Boston Scientific Corporation, Richard Wolf, FUJIFILM Holdings America Corporation, HOYA Corporation, Inc , B. Braun Melsungen AG, Renishaw plc., Cook,Ovesco Endoscopy AG Global Robotic Endoscopy Devices Market Competitive Landscape Analysis The competitive landscape analysis delivers information about the key competitors existing in the global market environment. Medrobotics Corporation Auris Health, Inc. Stryker, Medtronic Brainlab AG Smith + Nephew Intuitive Surgical Engineering GmbH EndoMaster Pte Ltd Boston Scientific Corporation Richard Wolf GmbH FUJIFILM Holdings America Corporation HOYA Corporation Inc (j&j surgical robotics) B. Braun Melsungen AG Renishaw plc. Cook, Ovesco Endoscopy AG Recent Developments In Feb 2022, Medtronic plc, a global leader in the healthcare technology, and the American Society for Gastrointestinal Endoscopy (ASGE) declared that they are working together to deliver colorectal cancer screening technologies in underserved and low income regions all across the United States through the Medtronic Health Equity Assistance Program for colon cancer screening, with support from Amazon Web Services (AWS). This initiative will include the contribution of 50 different Medtronic GI Genius intelligent modules of endoscopy to various endoscopy centers throughout the country that can potentfially improvise the identification of polyps which can lead to various colorectal cancer. In June 2021, Johnson & Johnson (US) launched its brand new product ENSEAL X1. It is the Curved Jaw Tissue Seale equipped with the advanced laparoscopic bipolar energy device increases procedural efficiency and provides more robust sealing & access to various body tissues. It is an intelligent and intuitive energy device that provides secure sealing and ease of use that improves currently available advanced bipolar sealing devices. Quest Innovations B.V. (Netherlands) was acquired by Olympus Corporation in January 2021, enabling Olympus to extend its surgical endoscopic capabilities and integrate Quest's superior Fluorescence imaging systems (FIS) capabilities into its full medical imaging offering. Fluorescence imaging refers to special light imaging technology that utilizes the properties of fluorescent dyes directed to specific anatomical structures. Various Leading Robotic Endoscopy Devices that Key Market Leaders Develop. Name of the product Function Key Players Invendoscope SC200 Used as a simple and effective solution to clinical and hygienic challenges. Invendo medical Endoscopy simulator It is a tool used for the instruction and training of learners and healthcare professionals. Kyoto Kagaku, Laparo Medical Simulators, MedVision Group, MEDVR, Nasco. NeoGuide Endoscopy System Used for diagnosis and treatment in the colon. Neoguide Systems Frequently Asked Question About This Report What is the Global Robotic Endoscopy Devices Market size in 2021? The robotic surgery market share was USD 1.60 billion in 2021. What are the critical Industry trends? The robotic endoscopy trends are the Rising prevalence of chronic diseases, high adoption of robotic endoscopy devices, and a rising number of market players. How big is the global robotic endoscopy market? The robotic endoscopy devices market forecast is to be USD 1.60 billion in 2021 to reach USD 5.49 billion by 2030. What are AI protocols in Endoscopic examination? Cerebro, ENDOANGEL, EndoBRAIN and Endomaster Who are the key robotic medical device companies? The endoscopy market leaders are FUJIFILM Holdings America Corporation, Medineering GmbH, EndoMaster Pte Ltd, Boston Scientific Corporation, Richard Wolf GmbH, HOYA Corporation, Johnson & Johnson Services, Inc( j&j surgical robotics). Sources https://www.census.gov/library/stories/2019/12/by-2030-all-baby-boomers-will-be-age-65-or-older.html https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991252/ https://iffgd.org/gi-disorders/irritable-bowel-syndrome/ https://www.who.int/news-room/fact-sheets/detail/ageing-and-health https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2021.html 1. Introduction 1.1. Study Objective 1.2. market Definition 1.3. Study Scope 1.3.1. markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing market Size by Top-Down Analysis 2.5. market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Robotic Endoscopy Devices Market Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 market Summary 4. Industry Outlook 4.1 market Snapshot 4.2 Global Robotic Endoscopy Devices market 4.2.1 Global Market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 market, by region, 2021 - 2030 (USD Million) 4.4 By Product Business Analysis 4.4.1 market, By Product, 2021 - 2030 (USD Million) 4.5 By End-User Business Analysis 4.5.1 market, By End-User, 2021 - 2030 (USD Million) 4.6 Application Business Analysis 4.6.1 market, By Application, 2021 - 2030 (USD Million) 4.7 Value Chain Analysis 4.8 market Variable Analysis 4.8.1 market Drivers Analysis 4.8.2 market Restraints Analysis 4.9Business Environment Analysis Tool 4.9.1 PEST analysis 4.9.2 Porter’s analysis 4.10 Penetration & Growth Prospect Mapping 5. Robotic Endoscopy Devices market Dynamics 5.1. Introduction 5.2. market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Application Analysis 5.11.1. Trends in Application (2014-2021) 5.11.2. Trends in Application (2021-2030) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company market Share Analysis 6.2. Manufacturers Robotic Endoscopy Manufacturing Sites, Area Served, Product Product 6.3. Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: By Product Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Diagnostic 7.3.1. Diagnostic market, 2021 - 2030 (USD Million) 7.4. Therapeutic 7.4.1. Therapeutic market, 2021 - 2030 (USD Million) 7.4.1.1 Biopsy (FNA and FNB) market, 2021 - 2030 (USD Million) 7.4.1.2 Polypectomy (Endoscopic submucosal dissection and Endoscopic Mucosal Resection) market, 2021 - 2030 (USD Million) 7.4.1.3 Biliary Stone Management & Drainage market, 2021 - 2030 (USD Million) 7.4.1.4 Hemostasis & Endoscopic suturing market, 2021 - 2030 (USD Million) 7.4.1.5 Esophageal & Colon Stricture Management market, 2021 - 2030 (USD Million) 7.4.1.6 Gastroesophageal Reflux Disease (GERD) & Obesity market, 2021 - 2030 (USD Million) 7.5. Others 7.5.1. Others market, 2021 - 2030 (USD Million) 8. Global Market: By End-User Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Hospitals 8.3.1. Hospitals market, 2021 - 2030 (USD Million) 8.4. Ambulatory Surgical Centers 8.4.1. Ambulatory Surgical Centers market, 2021 - 2030 (USD Million) 8.5. Others 8.5.1. Others market, 2021 - 2030 (USD Million) 9. Global Market: By Application Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Laparoscopy 9.3.1. Laparoscopy market, 2021 - 2030 (USD Million) 9.4. Bronchoscopy 9.4.1. Bronchoscopy market, 2021 - 2030 (USD Million) 9.5. Gastrointestinal devices 9.5.1. Gastrointestinal devices market, 2021 - 2030 (USD Million) 9.6. Colonoscopy devises 9.6.1. Colonoscopy devises market, 2021 - 2030 (USD Million) 10. Global Market: Regional Outlook 10.1 North America 10.1.1. North America By Product, 2021 - 2030 (USD Million) 10.1.2. North America By End-User, 2021 - 2030 (USD Million) 10.1.3. North America by Application, 2021 - 2030 (USD Million) 10.1.4. North America by Country, 2021 - 2030 (USD Million) 10.1.4.1. U.S. 10.1.4.1.1. U.S. By Product, 2021 - 2030 (USD Million) 10.1.4.1.2. U.S. By End-User, 2021 - 2030 (USD Million) 10.1.4.1.3. U.S. by Application, 2021 - 2030 (USD Million) 10.1.4.2.Canada 10.1.4.2.1. Canada By Product, 2021 - 2030 (USD Million) 10.1.4.2.2. Canada By End-User, 2021 - 2030 (USD Million) 10.1.4.2.3. Canada by Application, 2021 - 2030 (USD Million) 10.2. Europe 10.2.1. Europe By Product, 2021 - 2030 (USD Million) 10.2.2. Europe By End-User, 2021 - 2030 (USD Million) 10.2.3. Europe by Application, 2021 - 2030 (USD Million) 10.2.4. Europe by country, 2021 - 2030 (USD Million) 10.2.4.1 U.K. 10.2.4.1.1. U.K. By Product, 2021 - 2030 (USD Million) 10.2.4.1.2. U.K. By End-User, 2021 - 2030 (USD Million) 10.2.4.1.3. U.K.by Application, 2021 - 2030 (USD Million) 10.2.4.2. Germany 10.2.4.2.1. Germany By Product, 2021 - 2030 (USD Million) 10.2.4.2.2. Germany By End-User, 2021 - 2030 (USD Million) 10.2.4.2.3. Germany by Application, 2021 - 2030 (USD Million) 10.2.4.3. France 10.2.4.3.1. France By Product, 2021 - 2030 (USD Million) 10.2.4.3.2. France By End-User, 2021 - 2030 (USD Million) 10.2.4.3.3. France by Application, 2021 - 2030 (USD Million) 10.2.4.4. Rest of Europe 10.2.4.4.1. Rest of Europe By Product, 2021 - 2030 (USD Million) 10.2.4.4.2. Rest of Europe By End-User, 2021 - 2030 (USD Million) 10.2.4.4.3. Rest of Europe by Application, 2021 - 2030 (USD Million) 10.3. Asia Pacific 10.3.1. Asia Pacific By Product, 2021 - 2030 (USD Million) 10.3.2. Asia Pacific By End-User, 2021 - 2030 (USD Million) 10.3.3. Asia Pacific by Application, 2021 - 2030 (USD Million) 10.3.4. Asia Pacific by country, 2021 - 2030 (USD Million) 10.3.4.1. China 10.3.4.1.1. China By Product, 2021 - 2030 (USD Million) 10.3.4.1.2. China By End-User, 2021 - 2030 (USD Million) 10.3.4.1.3. China by Application, 2021 - 2030 (USD Million) 10.3.4.2. India 10.3.4.2.1. India By Product, 2021 - 2030 (USD Million) 10.3.4.2.2. India By End-User, 2021 - 2030 (USD Million) 10.3.4.2.3. India by Application, 2021 - 2030 (USD Million) 10.3.4.3. Japan 10.3.4.3.1. Japan By Product, 2021 - 2030 (USD Million) 10.3.4.3.2. Japan By End-User, 2021 - 2030 (USD Million) 10.3.4.3.3. Japan by Application, 2021 - 2030 (USD Million) 10.3.4.4. South Korea 10.3.4.4.1. South Korea By Product, 2021 - 2030 (USD Million) 10.3.4.4.2. South Korea By End-User, 2021 - 2030 (USD Million) 10.3.4.4.3. South Korea by Application, 2021 - 2030 (USD Million) 10.3.4.5. Rest of ASIA PACIFIC 10.3.4.5.1. Rest of ASIA PACIFIC By Product, 2021 - 2030 (USD Million) 10.3.4.5.2. Rest of ASIA PACIFIC, By End-User, 2021 - 2030 (USD Million) 10.3.4.5.3. Rest of ASIA PACIFIC by Application, 2021 - 2030 (USD Million) 10.4. Latin America 10.4.1. Latin America By Product, 2021 - 2030 (USD Million) 10.4.2. Latin America By End-User, 2021 - 2030 (USD Million) 10.4.3. Latin America by Application, 2021 - 2030 (USD Million) 10.4.4. Latin America by country, 2021 - 2030 (USD Million) 10.4.4.1. Brazil 10.4.4.1.1. Brazil By Product, 2021 - 2030 (USD Million) 10.4.4.1.2. Brazil By End-User, 2021 - 2030 (USD Million) 10.4.4.1.3. Brazil by Application, 2021 - 2030 (USD Million) 10.4.4.2. Mexico 10.4.4.2.1. Mexico By Product, 2021 - 2030 (USD Million) 10.4.4.2.2. Mexico By End-User, 2021 - 2030 (USD Million) 10.4.4.2.3. Mexico by Application, 2021 - 2030 (USD Million) 10.4.4.3. Rest of the Latin America 10.4.4.3.1. Rest of the Latin America By Product, 2021 - 2030 (USD Million) 10.4.4.3.2. Rest of the Latin America By End-User, 2021 - 2030 (USD Million) 10.4.4.3.3. Rest of the Latin America by Application, 2021 - 2030 (USD Million) 10.5. LAMEA 10.5.1. LAMEA By Product, 2021 - 2030 (USD Million) 10.5.2. LAMEA By End-User, 2021 - 2030 (USD Million) 10.5.3. LAMEA by Application, 2021 - 2030 (USD Million) 10.5.4. LAMEA by Region, 2021 - 2030 (USD Million) 11. Competitive Landscape 11.1 TransEnterix Surgical, Inc. 11.1.1. Company overview 11.1.2. Financial performance 11.1.3. ProductPortfolio Analysis 11.1.4. Business Strategy & Recent Development 11.2. MEDROBOTICS CORPORATION 11.2.1. Company overview 11.2.2. Financial performance 11.2.3. Product Portfolio Analysis 11.2.4. Business Strategy & Recent Development 11.3. AURIS HEALTH, INC. 11.3.1. Company overview 11.3.2. Financial performance 11.3.3. Product Portfolio Analysis 11.3.4. Business Strategy & Recent Development 11.4. KARL STORZ SE & CO KG 11.4.1. Company overview 11.4.2. Financial performance 11.4.3. Product Portfolio Analysis 11.4.4. Business Strategy & Recent Development 11.5. STRYKER, MEDTRONIC 11.5.1. Company overview 11.5.2. Financial performance 11.5.3. Product Portfolio Analysis 11.5.4. Business Strategy & Recent Development 11.6. Brainlab AG 11.6.1. Company overview 11.6.2. Financial performance 11.6.3. Product Portfolio Analysis 11.6.4. Business Strategy & Recent Development 11.7. Smith + Nephew 11.7.1. Company overview 11.7.2. Financial performance 11.7.3. Product Portfolio Analysis 11.7.4. Business Strategy & Recent Development 11.8. Intuitive Surgical 11.8.1. Company overview 11.8.2. Financial performance 11.8.3. Product Portfolio Analysis 11.8.4. Business Strategy & Recent Development 11.9. Engineering GmbH 11.9.1. Company overview 11.9.2. Financial performance 11.9.3. Product Portfolio Analysis 11.9.4. Business Strategy & Recent Development 11.10. EndoMaster Pte Ltd 11.10.1. Company overview 11.10.2. Financial performance 11.10.3. Product Portfolio Analysis 11.10.4. Business Strategy & Recent Development 11.11. Boston Scientific Corporation 11.11.1. Company overview 11.11.2. Financial performance 11.11.3. Product Portfolio Analysis 11.11.4. Business Strategy & Recent Development 11.12. Richard Wolf GmbH. 11.12.1. Company overview 11.12.2. Financial performance 11.12.3. Product Portfolio Analysis 11.12.4. Business Strategy & Recent Development 11.13. FUJIFILM Holdings America Corporation 11.13.1. Company overview 11.13.2. Financial performance 11.13.3. Product Portfolio Analysis 11.13.4. Business Strategy & Recent Development 11.14. HOYA Corporation 11.14.1. Company overview 11.14.2. Financial performance 11.14.3. Product Portfolio Analysis 11.14.4. Business Strategy & Recent Development 11.15. Johnson & Johnson Services, Inc(j&j surgical robotics) 11.15.1. Company overview 11.15.2. Financial performance 11.15.3. Product Portfolio Analysis 11.15.4. Business Strategy & Recent Development 11.16. B. Braun Melsungen AG 11.16.1. Company overview 11.16.2. Financial performance 11.16.3. Product Portfolio Analysis 11.16.4. Business Strategy & Recent Development 11.17. Renishaw plc. 11.17.1. Company overview 11.17.2. Financial performance 11.17.3. Product Portfolio Analysis 11.17.4. Business Strategy & Recent Development 11.18. Cook 11.18.1. Company overview 11.18.2. Financial performance 11.18.3. Product Portfolio Analysis 11.18.4. Business Strategy & Recent Development 11.19. Ovesco Endoscopy AG 11.19.1. Company overview 11.19.2. Financial performance 11.19.3. Product Portfolio Analysis 11.19.4. Business Strategy & Recent Development List of Tables (72 Tables) TABLE 1. By Product, 2021-2030 (USD Million) TABLE 2. FOR Diagnostic, BY REGION, 2021-2030 (USD Million) TABLE 3. FOR Therapeutic, BY REGION, 2021-2030 (USD Million) TABLE 4. FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 5. By End-User, 2021-2030 (USD Million) TABLE 6. FOR Hospitals, BY REGION, 2021-2030 (USD Million) TABLE 7. FOR Ambulatory Surgical Centers, BY REGION, 2021-2030 (USD Million) TABLE 8. FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 9. FOR Food & Beverages, BY REGION, 2021-2030 (USD Million) TABLE 10. FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 11. BY APPLICATION, 2021-2030 (USD Million) TABLE 12. FOR Laparoscopy, BY REGION, 2021-2030 (USD Million) TABLE 13. FOR Bronchoscopy, BY REGION, 2021-2030 (USD Million) TABLE 14. FOR Gastrointestinal devices, BY REGION, 2021-2030 (USD Million) TABLE 15. FOR Colonoscopy devises, BY REGION, 2021-2030 (USD Million) TABLE 16. FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 17. FOR Battery Powered Robotic Endoscopy, BY REGION, 2021-2030 (USD Million) TABLE 18. BY REGION, 2021-2030 (USD Million) TABLE 19. NORTH AMERICA BY COUNTRY, 2021-2030 (USD Million) TABLE 20. NORTH AMERICA By Product, 2021-2030 (USD Million) TABLE 21. NORTH AMERICA By End-User, 2021-2030 (USD Million) TABLE 22. NORTH AMERICA BY APPLICATION, 2021-2030 (USD Million) TABLE 23. EUROPE BY COUNTRY, 2021-2030 (USD Million) TABLE 24. EUROPE By Product, 2021-2030 (USD Million) TABLE 25. EUROPE By End-User, 2021-2030 (USD Million) TABLE 26. EUROPE BY APPLICATION, 2021-2030 (USD Million) TABLE 27. ASIA-PACIFIC BY COUNTRY, 2021-2030 (USD Million) TABLE 28. ASIA-PACIFIC By Product, 2021-2030 (USD Million) TABLE 29. ASIA-PACIFIC By End-User, 2021-2030 (USD Million) TABLE 30. ASIA-PACIFIC BY APPLICATION, 2021-2030 (USD Million) TABLE 31. LALAMEA BY COUNTRY, 2021-2030 (USD Million) TABLE 32. LALAMEA By Product, 2021-2030 (USD Million) TABLE 33. LALAMEA By End-User, 2021-2030 (USD Million) TABLE 34. LALAMEA BY APPLICATION, 2021-2030 (USD Million) TABLE 35. TransEnterix Surgical, Inc.: COMPANY SNAPSHOT TABLE 36. TransEnterix Surgical, Inc.: OPERATING SEGMENTS TABLE 37. MEDROBOTICS CORPORATION: COMPANY SNAPSHOT TABLE 38. MEDROBOTICS CORPORATION: OPERATING SEGMENTS TABLE 39. AURIS HEALTH, INC.: COMPANY SNAPSHOT TABLE 40. AURIS HEALTH, INC.: OPERATING SEGMENTS TABLE 41. KARL STORZ SE & CO KG : COMPANY SNAPSHOT TABLE 42. KARL STORZ SE & CO KG : OPERATING SEGMENTS TABLE 43. STRYKER, MEDTRONIC: COMPANY SNAPSHOT TABLE 44. STRYKER, MEDTRONIC: OPERATING SEGMENTS TABLE 45. Brainlab AG: COMPANY SNAPSHOT TABLE 46. Brainlab AG: OPERATING SEGMENTS TABLE 47. Smith + Nephew: COMPANY SNAPSHOT TABLE 48. Smith + Nephew: OPERATING SEGMENTS TABLE 49. Intuitive Surgical: COMPANY SNAPSHOT TABLE 50. Intuitive Surgical: OPERATING SEGMENTS TABLE 51. Engineering GmbH: COMPANY SNAPSHOT TABLE 52. Engineering GmbH: OPERATING SEGMENTS TABLE 53. EndoMaster Pte Ltd: COMPANY SNAPSHOT TABLE 54. EndoMaster Pte Ltd: OPERATING SEGMENTS TABLE 55. Boston Scientific Corporation: COMPANY SNAPSHOT TABLE 56. Boston Scientific Corporation: OPERATING SEGMENTS TABLE 57. Richard Wolf GmbH: COMPANY SNAPSHOT TABLE 58. Richard Wolf GmbH: OPERATING SEGMENTS TABLE 59. FUJIFILM Holdings America Corporation: COMPANY SNAPSHOT TABLE 60. FUJIFILM Holdings America Corporation: OPERATING SEGMENTS TABLE 61. HOYA Corporation: COMPANY SNAPSHOT TABLE 62. HOYA Corporation: OPERATING SEGMENTS TABLE 63. Johnson & Johnson Services, Inc(j&j surgical robotics): COMPANY SNAPSHOT TABLE 64. Johnson & Johnson Services, Inc(j&j surgical robotics): OPERATING SEGMENTS TABLE 65. B. Braun Melsungen AG: COMPANY SNAPSHOT TABLE 66. B. Braun Melsungen AG: OPERATING SEGMENTS TABLE 67. Renishaw plc.: COMPANY SNAPSHOT TABLE 68. Renishaw plc.: OPERATING SEGMENTS TABLE 69. Cook,: COMPANY SNAPSHOT TABLE 70. Cook, : OPERATING SEGMENTS TABLE 71. Ovesco Endoscopy AG: COMPANY SNAPSHOT TABLE 72. Ovesco Endoscopy AG: OPERATING SEGMENTS List of Figures (22 Figures) Figure 1 Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries Figure 4 Research Methodology: Hypothesis Building Figure 5 Product-Based Estimation Figure 6 Top 19 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2021 Figure 8 Import Data for Robotic Endoscopy Devices, By Country, 2016–2021 (USD Thousand) Figure 9 Export Data for Robotic Endoscopy Devices, By Country, 2016–2021 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 By End-User, 2019 vs. 2025 (USD Million) Figure 12 By Application, 2019 vs. 2025 (USD Million) Figure 13 By Product, 2019 vs. 2025 (USD Million) Figure 14 Geographical Snapshot Figure 15 Therapeutic to Witness Higher CAGR in the Product Segment during Forecast Period. Figure 16 Laparoscopy to Witness Higher CAGR in the Application Segment during Forecast Period. Figure 17 Hospitals to Witness Higher CAGR in the End-User Segment during Forecast Period. Figure 18 North America region Accounted for the Largest Share By Regional Basis, in 2019 Figure 19 Drivers, Restraints, Opportunities, and Challenges Figure 20 North America Snapshot Figure 21 Asia Pacific Snapshot Figure 22 Vendor Dive: Evaluation Overview